John Overdeck’s Ascendis Pharma A/S ASND Stock Holding History

John Overdeck’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.6M	Buy	305,803 +85,462	+39%	+$20M	0.06%	376
2026 Q1	$50.4M	Sell	220,341 -27,551	-11%	-$6.18M	0.04%	504
2025 Q4	$52.9M	Buy	247,892 +64,006	+35%	+$13.2M	0.07%	333
2025 Q3	$36.6M	Buy	183,886 +180,771	+5,803%	+$33.7M	0.05%	416
2025 Q2	$538K	Sell	3,115 -15,646	-83%	-$2.55M	﹤0.01%	2557
2025 Q1	$2.92M	Buy	18,761 +7,846	+72%	+$1.12M	0.01%	1484
2024 Q4	$1.5M	Sell	10,915 -39,173	-78%	-$5.15M	﹤0.01%	1914
2024 Q3	$7.48M	Sell	50,088 -205,232	-80%	-$27.7M	0.02%	892
2024 Q2	$34.8M	Buy	255,320 +44,995	+21%	+$6.12M	0.08%	299
2024 Q1	$31.8M	Buy	+210,325	New	+$30M	0.07%	313

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

John Overdeck's ASND Position: Q2 2026 in Review

John Overdeck increased its Ascendis Pharma A/S (ASND) stake by 39% in Q2 2026, buying an estimated $20M and bringing the position to 305,803 shares worth $81.6M. The position accounts for 0.06% of the portfolio, ranked #376.

John Overdeck first reported a position in ASND in Q1 2024 and has held it in 10 quarters since. 310 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

John Overdeck held 305,803 shares of Ascendis Pharma A/S worth $81.6M as of Q2 2026.
John Overdeck bought 85,462 Ascendis Pharma A/S shares in Q2 2026, an estimated $20M.
Ascendis Pharma A/S made up 0.06% of John Overdeck's portfolio in Q2 2026, its #376 holding.
John Overdeck first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 10 quarters since.
310 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.